Transcripts
CytomX Therapeutics (CTMX) earnings call transcripts
Earnings call transcripts for CytomX Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed Varsetta M as broadening from late-line CRC toward pivotal development, earlier-line combinations, and pan-GI expansion.
Aug 06, 2026Confident0.86